Analyst Price Targets — ADN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 20, 2022 12:33 pm | Laurence Alexander | Jefferies | $120.00 | $86.70 | Pulse 2.0 | Advent Technologies (ADN) Stock: $4 Target And Buy Rating |
Latest News for ADN
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of…
The blockbuster PayPal buyout could be off. Advent International and Stripe have reportedly walked away from their pursuit of the payments pioneer, ending months of speculation over a deal that would have ranked among the largest leveraged buyouts ever.
A consortium of buyout firm Advent and payment processor Stripe has decided to abandon its pursuit of fintech pioneer PayPal , Bloomberg News reported on Thursday, citing people familiar with the matter.
New brews, bold flavours and one unmissable 24-day countdown to Christmas New brews, bold flavours and one unmissable 24-day countdown to Christmas
The fintech startup and private-equity firm Advent offered to buy the struggling payments company in July
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ADN.
U.S. House Trading
No House trades found for ADN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.